Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a studyVolkan Granit, Matthew T. Duvernay, Marc H. Feinberg et al.|The Lancet Neurology|2023Cited by 255
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biologyMichael Benatar, Tahseen Mozaffar, Joanne Wuu et al.|Nature Reviews Neurology|2024Cited by 40
Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathyManisha Kak Korb, Kendrea L. Garand, Allison Peck et al.|Orphanet Journal of Rare Diseases|2022Cited by 36